Mohammadzadeh, YahyaDe Palma, Michele2022-04-252022-04-252022-04-252022-04-1110.1038/s41565-022-01089-1https://infoscience.epfl.ch/handle/20.500.14299/187298WOS:000780825800003A preclinical study reports a platform for the generation of dendritic cell-derived nanovesicles with enhanced immunostimulatory function, which demonstrate promising antitumoural activity in mouse models and might overcome some of the shortcomings of early-generation dendritic cell nanovaccines.Nanoscience & NanotechnologyMaterials Science, MultidisciplinaryScience & Technology - Other TopicsMaterials Scienceexosomestext::journal::journal article::research article